A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C

MeSH terms

• Antiviral Agents / administration & dosage
• Antiviral Agents / adverse effects
• Antiviral Agents / therapeutic use*
• Benzimidazoles / administration & dosage
• Benzimidazoles / adverse effects
• Benzimidazoles / therapeutic use*
• Drug Approval
• Drug Combinations
• Drug Interactions
• Fluorenes / administration & dosage
• Fluorenes / adverse effects
• Fluorenes / therapeutic use*
• Hepacivirus / genetics
• Hepatitis C, Chronic / drug therapy*
• Humans
• Sofosbuvir
• United States
• United States Food and Drug Administration
• Uridine Monophosphate / administration & dosage
• Uridine Monophosphate / adverse effects
• Uridine Monophosphate / analogs & derivatives*
• Uridine Monophosphate / therapeutic use